AB
Anushri Bhojraj Shetty
About Anushri Bhojraj Shetty
Data last updated:
Anushri Bhojraj Shetty is a Director at Vinder Pharma Private Limited (since 2019) and Additional Director at Ingress India Healthcare Private Limited (since 2019). The companies operate in Chemicals and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹1.99 Cr; the largest is Vinder Pharma Private Limited at ₹1.63 Cr (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 28 Nov 2019 | 2019 | ₹1.63 Cr (FY 2022) | Active | |
| Additional Director | 06 Nov 2019 | 2017 | ₹36 Lakh (FY 2022) | Active |
Board colleagues of Anushri Bhojraj Shetty
| Name | DIN | Company | Designation |
|---|---|---|---|
| Pradeep Subaya Shetty | 07969796 | Vinder Pharma Private Limited , Ingress India Healthcare Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anushri Bhojraj Shetty
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anushri Bhojraj Shetty
Anushri Bhojraj Shetty currently holds 2 directorships: Vinder Pharma Private Limited (Director, since 28 Nov 2019, revenue ₹1.63 Cr (FY 2022)); Ingress India Healthcare Private Limited (Additional Director, since 06 Nov 2019, revenue ₹36 Lakh (FY 2022)).
Anushri Bhojraj Shetty was first appointed on 06 Nov 2019 as Additional Director at Ingress India Healthcare Private Limited.
The 2 current companies of Anushri Bhojraj Shetty that report revenue have a combined latest revenue of ₹1.99 Cr: Vinder Pharma Private Limited ₹1.63 Cr (FY 2022); Ingress India Healthcare Private Limited ₹36 Lakh (FY 2022).
The current boards of Anushri Bhojraj Shetty's companies include Pradeep Subaya Shetty (Vinder Pharma Private Limited).